A B Figure S3 . Anti-SAIL ADCs do not affect viability of monocytes and proliferating T cells. Cell viability was assessed by measuring ATP levels in monocytes (A) or proliferating T cells (B) after 3 days of exposure to 7-1C-mcMMAF, a non-specific (ctrl) mouse IgG2a-mcMMAF, free MMAE or cytarabine. ATP levels [luminescence (CTG)] for each treatment were normalized against a no mAb treatment control. Results for two different PBMC donors are shown and the errors were estimated from the corresponding standard deviations. 
